Correlation Between Medigen Biotechnology and Taichung Commercial

Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Taichung Commercial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Taichung Commercial into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigen Biotechnology and Taichung Commercial Bank, you can compare the effects of market volatilities on Medigen Biotechnology and Taichung Commercial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Taichung Commercial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Taichung Commercial.

Diversification Opportunities for Medigen Biotechnology and Taichung Commercial

-0.56

Correlation Coefficient

Medigen Biotechnology  Taichung Commercial

Excellent diversification

The 3 months correlation between Medigen and Taichung is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Taichung Commercial Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taichung Commercial Bank and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Taichung Commercial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taichung Commercial Bank has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Taichung Commercial go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Taichung Commercial

Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the Taichung Commercial. In addition to that, Medigen Biotechnology is 1.85 times more volatile than Taichung Commercial Bank. It trades about -0.09 of its total potential returns per unit of risk. Taichung Commercial Bank is currently generating about -0.02 per unit of volatility. If you would invest  1,870  in Taichung Commercial Bank on September 29, 2024 and sell it today you would lose (10.00) from holding Taichung Commercial Bank or give up 0.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Medigen Biotechnology  vs.  Taichung Commercial Bank

Medigen Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Taichung Commercial Bank

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Taichung Commercial Bank are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Taichung Commercial is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Medigen Biotechnology and Taichung Commercial

The main advantage of trading using opposite Medigen Biotechnology and Taichung Commercial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Taichung Commercial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taichung Commercial will offset losses from the drop in Taichung Commercial's long position.

The idea behind Medigen Biotechnology and Taichung Commercial Bank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.